Protalix BioTherapeutics, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Protalix BioTherapeutics, Inc. Website Screenshot

http://www.protalix.com

Protalix BioTherapeutics, Inc. Company Intro

Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in Israel and internationally. The company offers Elelyso, a plant cell expressed recombinant glucocerebrosidase enzyme for the treatment of Gaucher disease. Its product pipeline comprises PRX-102, a therapeutic protein candidate, which is in phase III clinical trials for the treatment of Fabry diseases; OPRX-106, an orally-delivered protein product candidate for the treatment of inflammatory bowel disease, as well as completed Phase IIa clinical trial for ulcerative colitis patients; PRX-110, a proprietary plant cell recombinant form of human deoxyribonuclease I that has completed phase IIa clinical trials for the treatment of cystic fibrosis; and PRX-115, a plant cell-expressed recombinant PEGylated Uricase for the treatment of gout. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz (Fiocruz); and Chiesi Farmaceutici S.p.A. Protalix BioTherapeutics, Inc. was founded in 1993 and is headquartered in Karmiel, Israel.

Industry

Healthcare

Protalix BioTherapeutics, Inc. Headquaters

2 Snunit Street
Karmiel,2161401
Israel


Protalix BioTherapeutics, Inc. Share price

14 May 2021 02:24 GMT

$2.8700

-0.07 (-2.38 %)


Protalix BioTherapeutics, Inc. Market cap

$144.839 M


WMC RANKING

2021

Protalix BioTherapeutics, Inc. # 86

Biotechnology

Latest Protalix BioTherapeutics, Inc. News



WMC Market Score


WMC Market to Revenue Score


Protalix BioTherapeutics, Inc. Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Protalix BioTherapeutics, Inc. USD $64,620 $50,103 $-5,752 $1,448M 86
Regeneron Pharmaceuticals, Inc. USD $9,243,500 $5,152,600 $3,156,000 $540,220B 1
Vertex Pharmaceuticals Incorporated USD $6,205,683 $2,599,993 $2,711,647 $550,560B 2
Alexion Pharmaceuticals, Inc. USD $6,069,900 $2,656,500 $603,400 $380,130B 3
Incyte Corporation USD $2,229,409 $1,622,822 $446,906 $181,110B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Protalix BioTherapeutics, Inc. Social Followers vs Top 4 Industry Competitors



Protalix BioTherapeutics, Inc. Post vs Top 4 Industry Competitors




Protalix BioTherapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors



Protalix BioTherapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors



Protalix BioTherapeutics, Inc. WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Protalix BioTherapeutics, Inc. 0.70 0 0 0 0 0 0.01
Regeneron Pharmaceuticals, Inc. 100 23.93 2.32 100 0 0 48.53
Vertex Pharmaceuticals Incorporated 67.14 34.98 0.73 86 0 0 46.73
Alexion Pharmaceuticals, Inc. 65.67 100 100 60 0 0 100
Incyte Corporation 24.12 4.93 0.05 2 0 0 2.85

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries